v3.25.2
Common Stock - Schedule of Stockholders Equity Activity (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 09, 2025
May 07, 2024
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance (in shares)       135,487,595     135,487,595    
Net assets at beginning of period attributable to common stock     $ 1,898,833,000 $ 1,910,377,000 $ 1,998,558,000 $ 388,119,000 $ 1,910,377,000 $ 388,119,000 $ 388,119,000
Net investment income (loss)     39,580,000 44,924,000 48,677,000 49,737,000 84,504,000 98,414,000  
Net realized gain (loss) from investment transactions     (11,492,000) 3,452,000 250,000 1,283,000 (8,040,000) 1,533,000  
Net change in unrealized appreciation (depreciation) on investments     (1,930,000) (23,517,000) (16,015,000) (24,800,000) (25,447,000) (40,815,000)  
Accretion to redemption value of Series A redeemable convertible preferred stock     (4,000) (5,000) (4,000) (5,000)      
Accrual of Series A redeemable convertible preferred stock distributions     (1,687,000) (1,686,000) (1,687,000) (2,197,000)      
Distributions to common stockholders     (44,942,000) (44,703,000) (45,004,000) (11,182,000) (89,645,000) (56,186,000)  
Issuance of shares in connection with the Merger           1,594,261,000      
Issuance of common stock, net of issuance costs (in shares)                 110,096,838
Issuance of common stock, net of issuance costs         900,000   $ 0 900,000  
Repurchases (in shares) (2,475,427,000) (2,676,696,000)         (2,475,426)   (2,968,706)
Repurchases $ (34,903,490) $ (38,785,300) (34,903,000)   (41,170,000)   $ (34,903,000) (41,170,000) $ (43,017,000)
Reinvested dividends (in shares)             1,375,128   2,279,074
Reinvestment of common stockholder distributions     $ 9,292,000 9,991,000 $ 9,933,000 3,342,000 $ 19,283,000 $ 13,275,000 $ 33,106,000
Ending balance (in shares)     134,387,297   134,244,259   134,387,297 134,244,259 135,487,595
Net assets at end of period attributable to common stock     $ 1,852,747,000 $ 1,898,833,000 $ 1,954,438,000 $ 1,998,558,000 $ 1,852,747,000 $ 1,954,438,000 $ 1,910,377,000
Common Stock                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance (in shares)     136,196,142 135,487,595 136,335,073 26,080,389 135,487,595 26,080,389 26,080,389
Net assets at beginning of period attributable to common stock     $ 136,000 $ 135,000 $ 136,000 $ 26,000 $ 135,000 $ 26,000 $ 26,000
Issuance of shares in connection with the Merger (in shares)           110,033,324      
Issuance of shares in connection with the Merger           $ 110,000      
Issuance of common stock, net of issuance costs (in shares)         61,058        
Issuance of common stock, net of issuance costs         $ 1,000        
Repurchases (in shares)     (2,475,426)   (2,837,405)        
Repurchases     $ (2,000)   $ (3,000)        
Reinvested dividends (in shares)     666,581 708,547 685,533 221,360      
Reinvestment of common stockholder distributions     $ 1,000 $ 1,000 $ 1,000 $ 1,000      
Ending balance (in shares)     134,387,297 136,196,142 134,244,259 136,335,073 134,387,297 134,244,259 135,487,595
Net assets at end of period attributable to common stock     $ 135,000 $ 136,000 $ 134,000 $ 136,000 $ 135,000 $ 134,000 $ 135,000
Additional paid in capital                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net assets at beginning of period attributable to common stock     2,527,880,000 2,517,890,000 1,997,825,000 400,332,000 2,517,890,000 400,332,000 400,332,000
Issuance of shares in connection with the Merger           1,594,151,000      
Issuance of common stock, net of issuance costs         900,000        
Repurchases     (34,901,000)   (41,167,000)        
Reinvestment of common stockholder distributions     9,291,000 9,990,000 9,932,000 3,342,000      
Net assets at end of period attributable to common stock     2,502,270,000 2,527,880,000 1,967,490,000 1,997,825,000 2,502,270,000 1,967,490,000 2,517,890,000
Total distributable earnings (loss)                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net assets at beginning of period attributable to common stock     (629,183,000) (607,648,000) 597,000 (12,239,000) (607,648,000) (12,239,000) (12,239,000)
Net investment income (loss)     39,580,000 44,924,000 48,677,000 49,737,000      
Net realized gain (loss) from investment transactions     (11,492,000) 3,452,000 250,000 1,283,000      
Net change in unrealized appreciation (depreciation) on investments     (1,930,000) (23,517,000) (16,015,000) (24,800,000)      
Accretion to redemption value of Series A redeemable convertible preferred stock     (4,000) (5,000) (4,000) (5,000)      
Accrual of Series A redeemable convertible preferred stock distributions     (1,687,000) (1,686,000) (1,687,000) (2,197,000)      
Distributions to common stockholders     (44,942,000) (44,703,000) (45,004,000) (11,182,000)      
Net assets at end of period attributable to common stock     $ (649,658,000) $ (629,183,000) $ (13,186,000) $ 597,000 $ (649,658,000) $ (13,186,000) $ (607,648,000)